Directorate Change

RNS Number : 9485J
FastForward Innovations Limited
22 August 2019
 

22 August 2019

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

 

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

Board Changes

FastForward announces that Mr James Mellon has indicated a wish to step down from his roles as a director and Chairman of the Company to allow him to focus more time on his other business activities particularly Juvenescence Limited following the closing of this company's Series B funding as announced earlier this week.

 

Mr Lorne Abony has agreed to succeed Mr Mellon as Chairman of the Company on an interim basis while remaining as Chief Executive.

 

Mr Mellon remains the largest individual shareholder owning 10.08% of FFWD issued shares.

 

Lorne Abony commented: "The whole board would like to thank Jim for his service and assistance over the years. We fully understand Jim's decision to step down as he has many business commitments beyond FastForward which require his full attention and which increasingly absorb the bulk of his available time. Jim will help create value for our shareholders by driving forward the business at a number of our portfolio companies, while the other directors will continue to focus on creating long term value for our shareholders in line with our investment philosophy."

 

ENDS

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott /

Lance de Jersey

FastForward  Innovations Ltd

Email: info@fstfwd.co  

 

James Biddle /

Roland Cornish

Beaumont Cornish Limited

Nomad

Tel: +44 (0) 207 628 3396

 

Graham Dickson

Optiva Securities Limited

Broker

Tel: +44 (0) 203 411 1881

 

Gaby Jenner

St Brides Partners Ltd

Financial PR

Tel: +44 (0)207 236 1177

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKMGZRGZRGLZM
UK 100

Latest directors dealings